VQW-765 (AQW-051) is a selective and orally active alpha-7 nicotinic acetylcholine receptor (alpha7-nAChR) agonist with a pKD value of 7.56 to recombinantly expressed human alpha7-nAChR. VQW-765 shows anxiolytic-like effect in vivo. VQW-765 can be used for the research of anxiety disorder and acute performance anxiety[1].
Molecular Weight:
294.40
Purity:
99.58
CAS Number:
[669770-29-0]
Formula:
C19H22N2O
Target:
nAChR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted